Shanrong Biotechnology Corp. (SRBT)

Shanrong Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2015	FY 2014	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2015	Dec 31, 2014	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Revenue	-	-	1.32	0.69	0.75
Revenue Growth (YoY)	-	-	91.31%	-7.76%	108.15%
Gross Profit	-	-	1.32	0.69	0.75
Selling, General & Admin	0	0	2.71	2.98	1.69
Operating Expenses	0	0	6.13	3.11	2.64
Operating Income	-0	-0	-4.81	-2.41	-1.89
Interest Expense	-	-	-0.27	-0.31	-0.11
Other Non Operating Income (Expenses)	-	-	0	0	0
Pretax Income	-0	-0	-5.08	-2.72	-2
Net Income	-0	-0	-5.08	-2.72	-2
Net Income to Common	-0	-0	-5.08	-2.72	-2
Shares Outstanding (Basic)	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0
Shares Change (YoY)	-	50.09%	1.59%	23.34%	268.26%
EPS (Basic)	-0.00	-0.00	-15.72	-8.55	-7.74
EPS (Diluted)	-0.00	-0.00	-16.00	-9.00	-7.74
Free Cash Flow	-	-	-0.79	-1.46	-0.68
Free Cash Flow Per Share	-	-	-2.44	-4.58	-2.64
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-362.96%	-348.60%	-251.43%
Profit Margin	-	-	-383.32%	-392.78%	-265.87%
Free Cash Flow Margin	-	-	-59.44%	-210.28%	-90.59%
EBITDA	-	-	-4.77	-2.38	-1.85
EBITDA Margin	-	-	-	-	-246.69%
D&A For EBITDA	-	-	0.04	0.04	0.04
EBIT	-0	-0	-4.81	-2.41	-1.89
EBIT Margin	-	-	-	-	-251.43%
Advertising Expenses	-	-	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.